Cancer Stemness Kinase Inhibitor Amcasertib: A Promising Therapeutic Agent in Ovarian Cancer Stem and Cancer Cell Models With Different Genetic Profiles

Researchers evaluated the antineoplastic effects of Nanog inhibition, a critical transcription factor associated with pluripotency and its role in ovarian cancer tumorigenesis, using the novel therapeutic agent Amcasertib in ovarian cancer cells.